A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei

British Journal of Cancer

Volumn 95, Issue 9, 2006, Pages 1258-1264

  Bibi, R ^a   Pranesh, N ^a,b   Saunders, M P ^b   Wilson, M S ^b   O'Dwyer, S T ^b   Stern, P L ^a   Renehan, A G ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Cadherin; Cytokeratins; Pseudomyxoma peritonei; Vimentin

Indexed keywords

CADHERIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; MUCIN; NERVE CELL ADHESION MOLECULE; UVOMORULIN; VIMENTIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON MUCOSA; COLORECTAL ADENOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MESENCHYME CELL; METASTASIS; PERITONEUM PSEUDOMYXOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CA-15-3 ANTIGEN; CADHERINS; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-9; KERATIN-20; KERATIN-7; MALE; MIDDLE AGED; MUCINS; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; RECEPTORS, INTERLEUKIN-9; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 33750429599     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603398     Document Type: Article

References (35)

1. Bendardaf R, Elzagheid A, Lamlum H, Ristamaki R, Collan Y, Pyrhonen S (2005) E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer. Oncol Rep 13: 831-835
2. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM, Schalken JA (1993) Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53: 3241-3245
3. Brower M, Carney DN, Oie HK, Gazdar AF, Minna JD (1986) Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 46: 798-806
4. Bryant J, Clegg AJ, Sidhu MK, Brodin H, Royle P, Davidson P (2005) Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei. Br J Surg 92: 153-158
5. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD (2005) Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 97: 1124-1132
6. Dorudi S, Sheffield JP, Poulsom R, Northover JM, Hart IR (1993) E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142: 981-986
7. Esquivel J, Sugarbaker PH (2000) Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg 87: 1414-1418
8. Hauber HP, Manoukian JJ, Nguyen LH, Sobol SE, Levitt RC, Holroyd KJ, McElvaney NG, Griffin S, Hamid Q (2003) Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis. Laryngoscope 113: 1037-1042
9. Hazan RB, Kang L, Whooley BP, Borgen PI (1997) N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4: 399-411
10. Hernandez BY, Frierson HF, Moskaluk CA, Li YJ, Clegg L, Cote TR, McCusker ME, Hankey BF, Edwards BK, Goodman MT (2005) CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hum Pathol 36: 275-281
11. Hinson FL, Ambrose NS (1998) Pseudomyxoma peritonei. Br J Surg 85: 1332-1339
12. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR (1996) Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell- cell adhesion. J Cell Biol 135: 1643-1654
13. Kim YS, Gum Jr JR (1995) Diversity of mucin genes, structure, function, and expression. Gastroenterology 109: 999-1001
14. Kinzler KW, Vogelstein B (1998) Landscaping the cancer terrain. Science 280: 1036-1037
15. Lagendijk JH, Mullink H, van Diest PJ, Meijer GA, Meijer CJ (1999) Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol 52: 283-290
16. Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, Nicolaides NC (2000) Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 22: 649-656
17. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH (2003) Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 27: 1089-1103
18. Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH (2004) Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process. J Surg Oncol 86: 10-15
19. O'Connell JT, Hacker CM, Barsky SH (2002) MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol 15: 958-972
20. Remmele W, Schicketanz KH (1993) Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs subjective grading (IRS). Pathol Res Pract 189: 862-866
21. Renehan AG, O'Dwyer ST, Haboubi NJ, Potten CS (2002) Early cellular events in colorectal carcinogenesis. Colorectal Dis 4: 76-89
22. Rhodes A, Jasani B, Balaton AJ, Miller KD (2000) Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol 53: 292-301
23. Ronnett BM, Kurman RJ, Zahn CM, Shmookler BM, Jablonski KA, Kass ME, Sugarbaker PH (1995a) Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 26: 509-524
24. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (1995b) Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to 'pseudomyxoma peritonei'. Am J Surg Pathol 19: 1390-1408
25. Rosivatz E, Becker I, Bamba M, Schott C, Diebold J, Mayr D, Hofler H, Becker KF (2004) Neoexpression of N-cadherin in E-cadherin positive colon cancers. Int J Cancer 111: 711-719
26. Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML (2001) E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol 32: 690-697
27. Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA (1993) Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases. Am J Surg Pathol 17: 22-34
28. Starzynska T, Bromley M, Marlicz K, Roberts SA, Ucinski M, Stern PL (1997) Accumulation of p53 in relation to long-term prognosis in colorectal carcinoma. Eur J Gastroenterol Hepatol 9: 183-186
29. Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7: 69-76
30. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454
31. Tran NL, Nagle RB, Cress AE, Heimark RL (1999) N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 155: 787-798
32. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532
33. Weaver CH (1937) Mucocele of the appendix with pseuomucinous degeneration. Am J Surg 36: 523-526
34. Wilson JW, Nostro MC, Balzi M, Faraoni P, Cianchi F, Becciolini A, Potten CS (2000) Bcl-w expression in colorectal adenocarcinoma. Br J Cancer 82: 178-185
35. Young RH (2004) Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. Semin Diagn Pathol 21: 134-150